{"cluster": 69, "subcluster": 44, "abstract_summ": "CONCLUSIONS: Our recommendations emphasise the importance of treating cancer patients, using the best evidence available, while simultaneously taking into consideration the world-wide health resource hyperutilisation to treat non-cancer COVID-19 patients.Our objectives were to recommend evidence-based approaches to both treat and minimise the risk of COVID-19 for cancer patients, and simultaneously propose how to decrease the use of hospital resources at a time these resources need to be available to treat COVID-19 patients.To guide our clinical decisions at the National Cancer Institute of Milan (Lombardy region, the epicentre of the outbreak in Italy), we formulated Coronavirus-adapted Institutional recommendations for the systemic treatment of patients with gastrointestinal cancers.CONCLUSION This study shows that oncology patients in our country are more worried about disease progression than the SARS-CoV-2 and wish to continue chemotherapy during this pandemic.Therefore, there is a lack of guidance on how to manage cancer patients during the pandemic.", "title_summ": "Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours GroupSystemic treatment of patients with gastrointestinal cancers during the COVID-19 outbreak: COVID-19-adapted recommendations of the National Cancer Institute of MilanPerspective of Oncology Patients During COVID-19 Pandemic: A Prospective Observational Study From India.", "title_abstract_phrases": "CONCLUSIONS: Our recommendations emphasise the importance of treating cancer patients, using the best evidence available, while simultaneously taking into consideration the world-wide health resource hyperutilisation to treat non-cancer COVID-19 patients.Systemic treatment of patients with gastrointestinal cancers during the COVID-19 outbreak: COVID-19-adapted recommendations of the National Cancer Institute of MilanThe current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak poses a major challenge in the treatment decision making of cancer patients, who may be at higher risk of developing a severe and deadly SARS-CoV-2 infection compared to the general population.Our objectives were to recommend evidence-based approaches to both treat and minimise the risk of COVID-19 for cancer patients, and simultaneously propose how to decrease the use of hospital resources at a time these resources need to be available to treat COVID-19 patients.To guide our clinical decisions at the National Cancer Institute of Milan (Lombardy region, the epicentre of the outbreak in Italy), we formulated Coronavirus-adapted Institutional recommendations for the systemic treatment of patients with gastrointestinal cancers.Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours GroupPURPOSE: As of 2020, the world is facing the great challenge of the COVID-19 (Coronavirus disease 2019) pandemic, caused by the SARS-CoV-2 virus."}